Indivior reported 0.9 in EPS Earnings Per Share for its fiscal semester ending in March of 2026.





Eps Change Date
AstraZeneca USD 2.63 0.05 Jun/2026
Cassava Sciences USD -0.21 0.05 Mar/2026
GlaxoSmithKline GBP 0.51 0.08 Jun/2026
Glaxosmithkline GBP 0.62 0.41 Mar/2026
Hikma Pharmaceutical USD 0.65 0.12 Dec/2025
Roche Holding CHF 10.98 2.61 Jun/2026
West Pharmaceutical Services USD 2.37 0.24 Jun/2026